Issue 1: First nonclinical issue: diagnostic uncertainty in the classification of mammary masses in female rats.
FORBES: Merry Christmas! Here's Our Bad News
Issue 2: Second nonclinical issue: an uresolved exposure response relationship for lorcaserin-emergent mammary adenocarcinoma.
Issue 3: The third nonclinical issue: An unidentified mode of action and clear safety margin for lorcaserin.
The nonclinical experiments are most assuredly the brain homogenate and equilibrium dialysis methods I had described earlier.
应用推荐
模块上移
模块下移
不移动